Search

everythinglearnresearchcommunity

for

Search:↓

Exosome therapy may help treat diabetic nerve damage, but more research is needed.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Adipose mesenchymal stem cells are best for skincare because they reduce inflammation and are safe and effective.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Androgens increase cervical cancer risk and affect its development.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Metabolic signals and cell shape influence how cells develop and change.

scINSIGHT accurately identifies cell clusters and gene patterns in complex data.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Stem-cell therapy shows promise for skin conditions but needs more research.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Reporter characteristics affect detection of hair loss from cancer therapy.

Single-cell transcriptomics helps improve animal health and productivity by studying gene expression in individual cells.

Plasma-activated liquid can kill harmful cells, speed up wound healing, and potentially treat cancer without damaging healthy cells.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Lack of functional CYLD in mice leads to early aging and cancer.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.